Current challenges and the management of chronic hepatitis C in mainland China.

Duan, Zhongping; Jia, Ji-Dong; Hou, Jinlin; Lou, Lillian; Tobias, Hillel; Xu, Xiao Yuan; Wei, Lai; Zhuang, Hui; Pan, Calvin Q

Duan, Zhongping; Jia, Ji-Dong; Hou, Jinlin; Lou, Lillian; Tobias, Hillel; Xu, Xiao Yuan; Wei, Lai; Zhuang, Hui; Pan, Calvin Q.

Affiliation

Duan Z; *Artificial Liver Center, Beijing Youan Hospital Division of Hepatology, Friendship Hospital, Capital Medical University ¶Department of Infectious Diseases, Peking University First Hospital #Hepatology Institute, Peking University People's Hospital **Department of Microbiology and Center of Infectious Disease, School of Basic Medicine, Peking University Health Science Center, Peking University, Beijing Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou,

J Clin Gastroenterol ; 48(8): 679-86, 2014 Sep.

Article in En | MEDLINE | ID: mdl-24921215

Subject(s)

Antiviral Agents/therapeutic use; Hepacivirus/isolation & purification; Hepatitis C, Chronic/drug therapy; Antiviral Agents/adverse effects; China/epidemiology; Cost of Illness; Genotype; Hepacivirus/genetics; Hepatitis C, Chronic/epidemiology; Hepatitis C, Chronic/virology; Humans; Prevalence; Public Health; Risk Factors

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Hepacivirus / Hepatitis C, Chronic Type of study: Etiology_studies / Prevalence_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Asia Language: En Journal: J Clin Gastroenterol Year: 2014 Type: Article

Fulltext

XML

PubMed Links

Search on Google